GUTS compared with AMAN: revenue, margins and what each company keeps, and the suppliers and customers both name

GUTSFractyl Health, Inc.

Mkt capRevenueRevenue

AMANAmanat Acquisition Corp.

Mkt capRevenueRevenue

Compare

GUTSFractyl Health, Inc.

AMANAmanat Acquisition Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

GUTS, solidAMAN, dashed

Supply-chain overlap

Revenue flow

GUTS: latest quarter is a loss; flow not drawable. AMAN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GUTS 1

—Everself (formerly Bariendo)unlistedsupplier

Shared 0

No disclosed counterparties: AMAN.

Only AMAN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

GUTSFractyl Health, Inc.

0.98▼−0.73%· post 0.97

Mkt cap$13.0MRevenue$3,000Q4 FY24Revenue$93,000FY24

AMANAmanat Acquisition Corp.

10.20▲+0.49%· post 10.13

ClosedOct 30 '26

Mkt cap$54.4MRevenue—Revenue—

Compare

ClosedOct 30 '26

GUTSFractyl Health, Inc.

AMANAmanat Acquisition Corp.

0.98▼−0.73%post 0.97

Price

10.20▲+0.49%post 10.13

$13.0M

Mkt cap

$54.4M

Q4 FY24$3,000

Revenue

—

FY24$93,000

Revenue

—

GUTS0.98▼−0.73%vsAMAN10.20▲+0.49%ClosedOct 30 '26